• How Sunstone Therapies is Opening Doors to Psychedelic Treatment

  • Jun 1 2024
  • Duración: 47 m
  • Podcast

How Sunstone Therapies is Opening Doors to Psychedelic Treatment  Por  arte de portada

How Sunstone Therapies is Opening Doors to Psychedelic Treatment

  • Resumen

  • In this episode I speak to Norma Stevens, LCPC, the Director of Therapy Operations at Sunstone Therapies in Rockville, Maryland. Sunstone partners with companies like Beckley PsyTech, COMPASS Pathways, MindMed, MAPS (Lykos Theraputics), Reunion Neuroscience, and Usona to run studies that aim to establish the gold standard for psychedelic treatments of complex mental health challenges.

    Sunstone offers research trials in a unique partnership with the Acquilino Cancer Center, a research program within Adventist HealthCare. Sunstone works with psilocybin, MDMA, 5-MeO-DMT, and LSD in conjunction with psychotherapy. We discuss the role of psychological integration after a psychedelic journey and the importance of a therapeutic set and setting.

    Más Menos
activate_primeday_promo_in_buybox_DT

Lo que los oyentes dicen sobre How Sunstone Therapies is Opening Doors to Psychedelic Treatment

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.